Olicard 40 Retard

Olicard 40 Retard: an effective remedy for the treatment of heart diseases

Olycard 40 Retard is a pharmaceutical drug used to treat various cardiovascular diseases. It belongs to the group of antianginal agents, including nitrates and nitrites. The drug is manufactured by Solvay Pharmaceuticals GmbH in Germany and packaged under the PharmFirm Sotex brand in Germany and Russia.

Olycard 40 Retard contains the active substance isosorbide mononitrate, which is the international name of this drug. It is also known under various synonyms, including Iz 5 mono-Ratiopharm, Isomonat, Isomonit Hexal, Cardix mono, Konpin, Monizid, Monizol, Mono Mac, Mono Mac 50D, Mono Mac Depot, Monolong, Mononite, Mononitrate OF, Monosan, Monozinc, Monozinc retard.

The dosage form of Olicard 40 Retard is represented by retard capsules containing 40 mg of isosorbide mononitrate. The retard form means that the active substance is released gradually, providing a long-lasting effect of the drug.

Olicard 40 Retard is used to treat conditions such as angina pectoris (prevention), post-infarction period and chronic heart failure (in complex therapy). The drug has the ability to dilate blood vessels, improving blood supply to the heart and reducing the load on it. This helps reduce the frequency and intensity of angina attacks and improve the general condition of the patient.

However, Olicard 40 Retard also has contraindications. It is not recommended to use the drug in case of hypersensitivity to its components, acute myocardial infarction with reduced left ventricular filling pressure, cardiogenic shock, vascular collapse, severe arterial hypotension (with blood pressure less than 90 mmHg), hypertrophic obstructive cardiomyopathy, constrictive pericarditis, tamponade heart disease, cerebral hemorrhages, primary pulmonary hypertension, glaucoma, as well as during pregnancy and lactation.

When using Olicard 40 Retard, side effects may occur. Among the most common drugs is Olicard 40 Retard: an effective remedy for the treatment of heart diseases

Olycard 40 Retard is a pharmaceutical drug used to treat various cardiovascular diseases. It belongs to the group of antianginal agents, including nitrates and nitrites. The drug is manufactured by Solvay Pharmaceuticals GmbH in Germany and packaged under the PharmFirm Sotex brand in Germany and Russia.

Olycard 40 Retard contains the active substance isosorbide mononitrate, which is the international name of this drug. It is also known under various synonyms, including Iz 5 mono-Ratiopharm, Isomonat, Isomonit Hexal, Cardix mono, Konpin, Monizid, Monizol, Mono Mac, Mono Mac 50D, Mono Mac Depot, Monolong, Mononite, Mononitrate OF, Monosan, Monozinc, Monozinc retard.

The dosage form of Olicard 40 Retard is represented by retard capsules containing 40 mg of isosorbide mononitrate. The retard form means that the active substance is released gradually, providing a long-lasting effect of the drug.

Olicard 40 Retard is used to treat conditions such as angina pectoris (prevention), post-infarction period and chronic heart failure (in complex therapy). The drug has the ability to dilate blood vessels, improving blood supply to the heart and reducing the load on it. This helps reduce the frequency and intensity of angina attacks and improve the general condition of the patient.

However, Olicard 40 Retard also has contraindications. It is not recommended to use the drug in case of hypersensitivity to its components, acute myocardial infarction with reduced left ventricular filling pressure, cardiogenic shock, vascular collapse, severe arterial hypotension (with blood pressure less than 90 mmHg), hypertrophic obstructive cardiomyopathy, constrictive pericarditis, tamponade heart disease, cerebral hemorrhages, primary pulmonary hypertension, glaucoma, as well as during pregnancy and lactation.

When using Olicard 40 Retard, side effects may occur. Among the most common